| Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells S Matsuyama, N Nao, K Shirato, M Kawase, S Saito, I Takayama, ... Proceedings of the National Academy of Sciences 117 (13), 7001-7003, 2020 | 1440 | 2020 |
| Two cases of Zika fever imported from French Polynesia to Japan, December 2013 to January 2014 S Kutsuna, Y Kato, T Takasaki, ML Moi, A Kotaki, H Uemura, T Matono, ... Eurosurveillance 19 (4), 2014 | 227 | 2014 |
| Novel SARS-CoV-2 variant in travelers from Brazil to Japan T Fujino, H Nomoto, S Kutsuna, M Ujiie, T Suzuki, R Sato, T Fujimoto, ... Emerging infectious diseases 27 (4), 1243, 2021 | 210 | 2021 |
| Autochthonous dengue fever, tokyo, japan, 2014 S Kutsuna, Y Kato, ML Moi, A Kotaki, M Ota, K Shinohara, T Kobayashi, ... Emerging infectious diseases 21 (3), 517, 2015 | 201 | 2015 |
| Prolonged and late-onset symptoms of coronavirus disease 2019 Y Miyazato, S Morioka, S Tsuzuki, M Akashi, Y Osanai, K Tanaka, ... Open forum infectious diseases 7 (11), ofaa507, 2020 | 151 | 2020 |
| Clinical determinants of the severity of Middle East respiratory syndrome (MERS): a systematic review and meta-analysis R Matsuyama, H Nishiura, S Kutsuna, K Hayakawa, N Ohmagari BMC public health 16, 1-10, 2016 | 134 | 2016 |
| Zika fever imported from Thailand to Japan, and diagnosed by PCR in the urine K Shinohara, S Kutsuna, T Takasaki, ML Moi, M Ikeda, A Kotaki, ... Journal of travel medicine 23 (1), tav011, 2016 | 132 | 2016 |
| Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan M Terada, H Ohtsu, S Saito, K Hayakawa, S Tsuzuki, Y Asai, ... BMJ open 11 (6), e047007, 2021 | 105 | 2021 |
| Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains R Hamasuna, PT Le, S Kutsuna, K Furubayashi, M Matsumoto, ... PLoS One 13 (6), e0198355, 2018 | 97 | 2018 |
| Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19 M Sugiyama, N Kinoshita, S Ide, H Nomoto, T Nakamoto, S Saito, ... Gene 766, 145145, 2021 | 95 | 2021 |
| Prevalence and associated factors for delirium in critically ill patients at a Japanese intensive care unit R Tsuruta, T Nakahara, T Miyauchi, S Kutsuna, Y Ogino, T Yamamoto, ... General hospital psychiatry 32 (6), 607-611, 2010 | 93 | 2010 |
| Xanthine oxidase is one of the major sources of superoxide anion radicals in blood after reperfusion in rats with forebrain ischemia/reperfusion T Ono, R Tsuruta, M Fujita, HS Aki, S Kutsuna, Y Kawamura, J Wakatsuki, ... Brain research 1305, 158-167, 2009 | 92 | 2009 |
| Parvimonas micra as a causative organism of spondylodiscitis: a report of two cases and a literature review H Uemura, K Hayakawa, K Shimada, M Tojo, M Nagamatsu, ... International Journal of Infectious Diseases 23, 53-55, 2014 | 69 | 2014 |
| First case of Plasmodium knowlesi infection in a Japanese traveller returning from Malaysia R Tanizaki, M Ujiie, Y Kato, M Iwagami, A Hashimoto, S Kutsuna, ... Malaria journal 12, 1-4, 2013 | 60 | 2013 |
| Molecular and epidemiological characterization of IMP-type metallo-β-lactamase-producing Enterobacter cloacae in a large tertiary care hospital in Japan K Hayakawa, T Miyoshi-Akiyama, T Kirikae, M Nagamatsu, K Shimada, ... Antimicrobial agents and chemotherapy 58 (6), 3441-3450, 2014 | 52 | 2014 |
| Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers T Suzuki, K Hayakawa, A Ainai, N Iwata-Yoshikawa, K Sano, N Nagata, ... Journal of Infection and Chemotherapy 27 (1), 120-122, 2021 | 51 | 2021 |
| Severe acute respiratory syndrome coronavirus 2 infection among returnees to Japan from Wuhan, China, 2020 Y Arima, S Kutsuna, T Shimada, M Suzuki, T Suzuki, Y Kobayashi, ... Emerging infectious diseases 26 (7), 1596, 2020 | 44 | 2020 |
| Association of HLA‐DRB1*09:01 with severe COVID‐19 A Anzurez, I Naka, S Miki, K Nakayama‐Hosoya, M Isshiki, Y Watanabe, ... Hla 98 (1), 37-42, 2021 | 39 | 2021 |
| Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma K Maeda, N Higashi-Kuwata, N Kinoshita, S Kutsuna, K Tsuchiya, ... Scientific Reports 11 (1), 5563, 2021 | 39 | 2021 |
| Two cases of granulomatous mastitis caused by Corynebacterium kroppenstedtii infection in nulliparous young women with hyperprolactinemia S Kutsuna, K Mezaki, M Nagamatsu, J Kunimatsu, K Yamamoto, Y Fujiya, ... Internal Medicine 54 (14), 1815-1818, 2015 | 39 | 2015 |
Norio Ohmagari, MD, MSc, Ph.D.Director, Disease Control and Prevention Center National Center for Global Health and Medicine在 hosp.ncgm.go.jp 的电子邮件经过验证
